Tilray Inc (TLRY) support and resistance · rev $821.3M
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This page maps Tilray Inc (TLRY) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TLRY revenue for 2025-05-31 was $821.3M. Net income was -$2.18B. Revenue was up 4.1% from 2024-05-31 to 2025-05-31. TLRY currently screens at market cap $573.9M.
TLRY currently screens at market cap $573.9M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TLRY 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TLRY quote page for the session range and the stock page for the full model.
Not investment advice.